CS logo
small CS logo
Virginia Oncology Associates

Newport News, Virginia, United States
Oncologist in Newport News, Virginia
1051 Loftis Blvd Suite 100, Newport News, VA 23606

About Virginia Oncology Associates


"Virginia Oncology Associates is an oncology and hematology practice of physicians, specializing in the diagnosis and treatment of cancer and blood disorders. With locations spanning the southeast region of Virginia and Northeastern North Carolina, we are able to extend services and treatments to patients, including medical oncology, radiation oncology, gynecologic oncology, hematology, diagnostics, clinical research, stem cell transplantation, genetic counseling, and psychosocial oncology."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
NSABP Foundation Inc
8
Pfizer
7
Gilead Sciences
3
Alliance for Clinical Trials in Oncology
2
Cascadian Therapeutics Inc.
2
Hoffmann-La Roche
2
US Oncology Research
2
Active Biotech AB
1
Agennix
1
Astellas Pharma Inc
1
Bayer
1
Total Rows: 25

Clinical Trials at Virginia Oncology Associates


During the past decade, Virginia Oncology Associates conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111133113333222200004400Started TrialsCompleted Trails2017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
1994-08-01
2009-11-01
Completed
810
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
1995-12-01
2010-02-01
Completed
2,411
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
1997-05-01
2006-03-01
Completed
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
1996-08-01
2000-11-01
Completed
6
Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
1998-06-01
2002-12-01
Completed
89
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
1999-05-01
2014-02-01
Completed
5,611
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747

Rows per page:

1–44 of 44

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Virginia Oncology Associates" #1 sponsor was "NSABP Foundation Inc" with 8 trials, followed by "Pfizer" with 7 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "Cascadian Therapeutics Inc." with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNSABP Foundation Inc: 8NSABP Foundation Inc: 8Pfizer: 7Pfizer: 7Gilead Sciences: 3Gilead Sciences: 3Alliance for ClinicalTrials in Oncology: 2Alliance for ClinicalTrials in Oncology: 2Cascadian Therapeutics Inc.: 2Cascadian Therapeutics Inc.: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2US Oncology Research: 2US Oncology Research: 2Active Biotech AB: 1Active Biotech AB: 1Agennix: 1Agennix: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 10National CancerInstitute (NCI): 10Astellas Pharma Inc: 3Astellas Pharma Inc: 3Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:3Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:3Genentech, Inc.: 2Genentech, Inc.: 2AstraZeneca: 1AstraZeneca: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Life Technologies, Inc.: 1Life Technologies, Inc.: 1Medivation, Inc.: 1Medivation, Inc.: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1

Clinical Trials Conditions at Virginia Oncology Associates


According to Clinical.Site data, the most researched conditions in "Virginia Oncology Associates" are "Breast Cancer" (14 trials), "Colorectal Cancer" (4 trials), "Prostate Cancer" (3 trials), "Triple Negative Breast Cancer" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Virginia Oncology Associates" in a lesser frequency.

Clinical Trials Intervention Types at Virginia Oncology Associates


Most popular intervention types in "Virginia Oncology Associates" are "Drug" (38 trials), "Biological" (3 trials), "Procedure" (3 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Paclitaxel" (5 trials), "Gemcitabine" (4 trials), "cyclophosphamide" (4 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Virginia Oncology Associates


The vast majority of trials in "Virginia Oncology Associates" are 23 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Virginia Oncology Associates


Currently, there are NaN active trials in "Virginia Oncology Associates". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Virginia Oncology Associates, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Virginia Oncology Associates, 5 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 27Phase 3: 27Phase 2: 12Phase 2: 12Phase 1: 5Phase 1: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 26Completed: 26Recruiting: 7Recruiting: 7Terminated: 7Terminated: 7Active, not recruiting: 3Active, not recruiting: 3Unknown status: 1Unknown status: 1